The Department of Veterans Affairs Veterans Health Administration awarded Boston Scientific Corporation a single award indefinite delivery contract to supply coronary stents. The contract has a potential value of $541,250 and a period of performance through August 2027. Under the contract, Boston Scientific will provide a broad range of drug-eluting coronary stents to various VA medical centers. Specifically, the original solicitation indicated the contract would procure over 100 models of Boston Scientific's Synergy XD MR stent portfolio. As the leading cause of death among US veterans, coronary heart disease represents a major healthcare challenge for the VA. Ensuring an adequate supply of proven stents like those offered by Boston Scientific supports the agency's mission of providing veterans access to life-saving cardiovascular treatments. The indefinite delivery contract mechanism allows individual VA medical facilities to issue delivery orders on an as-needed basis, offering flexibility to address patients' needs over the five-year period of performance. No set-aside provisions were used for this single award to Boston Scientific, consistent with the VA's justification provided in the original special notice that only the awardee's stents would meet requirements. The contract facilitates the VA's ability to treat veterans' cardiovascular conditions through a pre-competed supply of specialized coronary stents.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 8/2/22 |
Name | Description | Solicitation Number | Federal Agency | Type | Posted Date (Click to sort descending) |
|---|---|---|---|---|---|
NOTICE OF INTENT TO SOLE SOURCE BOSTON SCIENTIFIC | 36C25922Q0502 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 | Special Notice 1/1 | 7/12/22, 4:51 PM |